Netherlands· NL-42fac9abb9ea

Austedo 36 mg tabletten met verlengde afgifte

A deutetrabenazine product containing deutetrabenazine, registered in Netherlands by Teva GmbH. The same ATC class is registered in 9 of our 19 countries.

ATC N07XX16

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about deutetrabenazineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Deutetrabenazine is registered in 9 of 19 countries.

Countries holding a registration under ATC N07XX16 (deutetrabenazine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search deutetrabenazine products by name

Deutetrabenazine · ATC N07XX16

9 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Polandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: DEUTETRABENAZINE
Manufacturer: Teva GmbH
Country: Netherlands (NL)
ATC code: N07XX16
ATC class: Deutetrabenazine
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/25/1956

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

219 interactions on record for deutetrabenazine.

Graded by severity as the source publishes them — 53 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check deutetrabenazine against other medicines How interaction checks work

Deutetrabenazine · interactions on record

219 records

53 severe
164 moderate
2 minor

Most severe, free to view

PapaverineA03AD01severe
MetoclopramideA03FA01severe
CisaprideA03FA02severe
DolasetronA04AA04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Deutetrabenazine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deutetrabenazine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

United Kingdom (Northern Ireland) · Austedo
Iceland · Austedo
Liechtenstein · Austedo
Norway · Austedo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/476120c1-4e11-4e7e-9f50-5047255565a4
GET /v1/drugs/476120c1-4e11-4e7e-9f50-5047255565a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/austedo-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Deutetrabenazine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp133169",
  "excipients": [
    "ALLURAROOD AC ALUMINIUM LAK (E 129)",
    "BUTYLHYDROXYANISOL (E 320)",
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "CELLULOSEACETAAT",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ZWART (E 172)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "MACROGOL 200000",
    "MACROGOL 3350",
    "MACROGOL 5000000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMCHLORIDE",
    "POLYVINYLALCOHOL (E 1203)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "ZONNEGEEL FCF ALUMINIUMLAK (E 110)",
    "ZWARTE INKT"
  ],
  "substances": [
    "DEUTETRABENAZINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2026/01/08",
  "procedure_number": "EMEA/H/C/006371",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/25/1956",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about deutetrabenazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console